Source: Medelis Blog

Medelis Blog Transforming Oncology Drug Development with Artificial Intelligence

The release of GPT 3.5 and the improvement of large language models (LLMs) has captured the imagination of many around... [read more]The post Transforming Oncology Drug Development with Artificial Intelligence appeared first on Medelis.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

President & CEO

Dan Weng

CEO Approval Rating

90/100

Read more